Lantern Pharma (LTRN) Earnings
|
Expand Research on LTRN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +22.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +9.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/26  |
Q425 | N/A | -$0.54 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/5/26 |
Q425 | N/A | -$0.54 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/25 |
Q325 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/25 |
Q225 | -$0.40 | -$0.53 | +$0.13 | N/A | N/A | N/A |  | | Details | |
| 8/6/25 |
Q225 | N/A | -$0.53 | N/A | N/A | N/A | N/A | N/A | N/A |
